Archerchem is going to pursue its in–house research and development initiative

2012 turned out to be landmark year for Archerchem. It was the year of diversification, of expansion, of achieving another important milestone. With a firm foot in pharmaceutical value chain supply, Anil Dhedia, the man with flawless foresight realized the time had come for an upstream vertical integration. With over a decade of experience in supplying basic raw materials, the next obvious step was to enter into the finished products market. Archerchem once again became a driving force in this domain with sales jumping year on year, including ( DCG ) or Directly Compressible Granules area.

Archerchem’s intelligent product selection not only offered commercial success and accolades but also provided a meaningful and tangible change, improving the lives of those impacted with health issues further.

Archerchem is going to pursue its in–house research and development initiative to leverage homegrown technology to deliver newer solutions so that our commitment to care remains intact for years and years to come.